Prellis Biologics Enters Multi-Target Drug Discovery & Development Collaboration with Lilly to Advance Human Antibody Therapeutics

by Libby Ward | Sep 23, 2025 | Uncategorized | 0 comments

Contact Us

Lucas Venture Group

555 Bryant Street, #239
Palo Alto, CA 94301

"*" indicates required fields

Name

This field is for validation purposes and should be left unchanged.

Name*

Name

Email*

Message*

Consent*

I Agree To The Privacy Policy and Terms Of Service

Home
About
Team
Investments
- Current
- Exits
Press
Contact

GDPR Cookie Banner

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enabled Disabled

Google Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.